CYP17 POLYMORPHISMS AND PROSTATE CANCER OUTCOMES

被引：0
|
作者：
Wright, Jonathan L.
Lin, Daniel W.
Kwon, Erika M.
Kolb, Suzanne
Feng, Ziding
Koopmeiners, Joseph
Ostrander, Elaine A.
Stanford, Janet L.
机构：
来源：
JOURNAL OF UROLOGY | 2009年 / 181卷 / 04期
关键词：
D O I：
10.1016/S0022-5347(09)62164-9
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
2142
引用
收藏
页码：777 / 777
页数：1
相关论文
共 50 条
  • [1] CYP17 Polymorphisms and Prostate Cancer Outcomes
    Wright, Jonathan L.
    Kwon, Erika M.
    Lin, Daniel W.
    Kolb, Suzanne
    Koopmeiners, Joseph S.
    Feng, Ziding
    Ostrander, Elaine A.
    Stanford, Janet L.
    PROSTATE, 2010, 70 (10): : 1094 - 1101
  • [2] CYP17 polymorphisms and prostate cancer
    不详
    EUROPEAN UROLOGY SUPPLEMENTS, 2005, 4 (03) : 182 - 182
  • [3] Relationship between CYP17 gene polymorphisms and risk of prostate cancer
    Song, J.
    Tao, Z. -H.
    Liu, X. -Y.
    Gong, S.
    Gan, L.
    GENETICS AND MOLECULAR RESEARCH, 2016, 15 (01)
  • [4] Polymorphisms in CYP17 and CYP3A4 and prostate cancer in men of African descent
    Taioli, Emanuela
    Sears, Vestra
    Watson, Alexis
    Flores-Obando, Rafael E.
    Jackson, Maria D.
    Ukoli, Flora A.
    de Syllos Colus, Ilce M.
    Fernandez, Pedro
    McFarlane-Anderson, Norma
    Ostrander, Elaine A.
    Rodrigues, Iara S.
    Stanford, Janet L.
    Taylor, Jack A.
    Tulloch-Reid, Marshall
    Ragin, Camille C. R.
    PROSTATE, 2013, 73 (06): : 668 - 676
  • [5] CYP17 inhibitors for prostate cancer therapy
    Vasaitis, Tadas S.
    Bruno, Robert D.
    Njar, Vincent C. O.
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2011, 125 (1-2): : 23 - 31
  • [6] CYP17 gene polymorphism in prostate cancer
    Sivonova, M.
    Dobrota, D.
    Matakova, T.
    Racay, P.
    Hatok, J.
    Kliment, J.
    EJC SUPPLEMENTS, 2009, 7 (02): : 415 - 415
  • [7] Prostate cancer associated with CYP17 genotype
    Wadelius, M
    Andersson, SO
    Johansson, JE
    Wadelius, C
    Rane, A
    PHARMACOGENETICS, 1999, 9 (05): : 635 - 639
  • [8] CYP17 inhibitors for prostate cancer treatment - An update
    Moreira, V. M.
    Salvador, J. A. R.
    Vasaitis, T. S.
    Njar, V. C. O.
    CURRENT MEDICINAL CHEMISTRY, 2008, 15 (09) : 868 - 899
  • [9] CYP17 inhibition as a hormonal strategy for prostate cancer
    Reid, Alison H. M.
    Attard, Gerhardt
    Barrie, Elaine
    de Bono, Johann S.
    NATURE CLINICAL PRACTICE UROLOGY, 2008, 5 (11): : 610 - 620
  • [10] A polymorphism in the CYP17 gene and risk of prostate cancer
    Stanford, JL
    Noonan, EA
    Iwasaki, L
    Kolb, S
    Chadwick, RB
    Feng, ZD
    Ostrander, EA
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2002, 11 (03) : 243 - 247
12345